Related Experiment Video
Updated: Jul 17, 2026
10:27
Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
Acquired hyper-IgM syndrome with necrotizing granuloma.
The Journal of Allergy and Clinical Immunology
|April 1, 1985
Summary
This study reports idiopathic necrotizing granulomas in lymph nodes of a patient with acquired hyper-IgM syndrome, a novel finding. The research details the granuloma composition and lymphocyte distribution using advanced techniques.
Area of Science:
- Immunology
- Pathology
Background:
- Acquired hyper-IgM syndrome is a rare immunodeficiency characterized by normal or elevated IgM levels with deficient IgG, IgA, and IgE.
- Cervical lymphadenopathy can occur in various conditions, but specific pathological findings in hyper-IgM syndrome are not well-documented.
Observation:
- The study observed significant cervical lymphadenopathy in a patient diagnosed with acquired hyper-IgM syndrome.
- Histopathological examination revealed idiopathic necrotizing granulomas within the affected lymph nodes, a previously unreported feature for this syndrome.
Findings:
- Immunoperoxidase staining identified necrotizing granulomas composed of Ia-positive epithelioid histiocytes and T11-positive inflammatory cells.
- Analysis showed a lack of IgG-bearing lymphocytes in germinal centers and reduced IgA/IgG plasma cells in interfollicular regions.
- Peripheral blood mononuclear cells exhibited diminished IgA and IgG secretion in response to pokeweed mitogen stimulation.
Implications:
- This finding expands the pathological spectrum of acquired hyper-IgM syndrome.
- The use of monoclonal antibodies provides insights into nodal lymphocyte distribution in this disorder.
- Further research may clarify the role of granuloma formation in the pathogenesis of hyper-IgM syndrome.
Related Concept Videos
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:12Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
01:19Hypersensitivity Reactions: Immune-Complex Reactions
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...